Showing results (71-80 of 76) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Neuro-Oncology|November 10, 2017
Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastomaNiklas Schäfer, Martin Proescholdt, Joachim P Steinbach, et al.Nature Communications|April 8, 2026
L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy and bevacizumab in newly-diagnosed glioblastoma: expansion of the phase I/II GLORIA trialFrank A Giordano, Julian P Layer, Roberta Turiello, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2022
A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in GlioblastomaSied Kebir, Vivien Ullrich, Pia Berger, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2016
Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS TrialUlrich Herrlinger, Niklas Schäfer, Joachim P Steinbach, et al.Lancet (London, England)|February 21, 2019
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trialUlrich Herrlinger, Theophilos Tzaridis, Frederic Mack, et al.Nature Communications|August 10, 2024
A real-world observation of patients with glioblastoma treated with a personalized peptide vaccinePauline Latzer, Henning Zelba, Florian Battke, et al.Pageof 8